SEATTLE – July 2, 2019 – Accolade, a personalized advocacy solution for employers, health plans and their members, today announced Dawn Lepore, former chairman and CEO of drugstore.com, to its board of directors, effective today.
“Dawn is an exceptional addition to our board. Her impressive background in healthcare and business, from small to large companies and those managing corporate growth are right in line with our strategy,” said Rajeev Singh, Accolade CEO. “Dawn is a strategic thinker in technology, e-commerce, building marketplaces, user acquisition and engagement, which blends extremely well with our board mix and what we’re doing to grow our community and deliver the most impactful solutions to self-insured employers.”
Lepore has held executive and board positions with some of the most respected brands in business. As CEO and chairman of the board of drugstore.com she repositioned the company to focus on the over-the-counter, beauty, and vision businesses and led the company to record revenues and acquisition by Walgreens in 2011. Lepore spent 21 years at Charles Schwab in various leadership roles, including vice chairman of technology, CIO, and strategy and operations positions.
Lepore has been recognized professionally by multiple industry groups, including Fortune Magazine four times as one of the “50 Most Powerful Women in American Business,” the National Organization for Women at their Aiming High Conference, InformationWeek’s “Chiefs of the Year,” and one of the “Ten Hottest CIOs” by Future Banker Magazine. Lepore graduated from Smith College in Northampton, Massachusetts.
“Accolade has captured my interest for several years because of the unique way they blend technology and people to provide a personalized experience,” said Lepore. “Like many of Accolade’s employees and board members, I have a personal interest in the support Accolade provides. My family experienced a health crisis, and finding and understanding our healthcare options was confusing and stressful. I am excited to apply my experience and personal passion to Accolade’s mission of helping millions of families and their employers.”
Lepore joins Accolade Board members Edgar Bronfman, managing partner at Accretive; J. Michael Cline, Accolade co-founder and founding partner at Accretive; Bill Frist, MD, nationally acclaimed heart and lung transplant surgeon and former U.S. Senate Majority Leader and chairman of the executive board of Cressey & Company; Jeff Jordan, general partner at Andreessen Horowitz; Jim Madden, co-founder and managing director of Carrick Capital Partners; Tom Neff with Spencer Stuart; Tom Spann, co-founder of Accolade and CEO of Brightside; and Michael Yang, Managing Partner at OMERS Ventures, and previously Managing Director at Comcast Ventures.
In addition to Accolade, Lepore serves on the boards of loanDepot, RealNetworks and Servco Pacific Insurance. She has previously held board positions at eBay, Walmart, TJX Companies, AOL, Quotient, and The New York Times Company.
Accolade is a personalized health and benefits solution that can dramatically improve the experience, outcomes and cost of healthcare for employers, health plans and their members. With a unique blend of compassionate advisors, clinical experts and intelligent technologies, we engage individuals and families in their health, establish trust, and influence their decisions at every stage of care. Accolade connects the widest array of personal health data and programs to present a single point of entry to the most effective health and benefits resources, while coordinating with providers at every step. Accolade consistently achieves 60 and higher Net Promoter Scores, 98% consumer satisfaction ratings, and up to 15% employer cost savings. Accolade has been recognized as one of the nation’s 25 most promising companies by Forbes, a fastest-growing private healthcare company by Inc. 5000, and is consistently rated a Top Workplace across the country. For more information, visit www.accolade.com.